Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response.
about
An update on vaccine therapy and other immunotherapeutic approaches for glioblastomaIntegration of epidemiology, immunobiology, and translational research for brain tumorsCombining cytotoxic and immune-mediated gene therapy to treat brain tumorsImmunocompetent murine models for the study of glioblastoma immunotherapyEffective immunotherapy against murine gliomas using type 1 polarizing dendritic cells--significant roles of CXCL10.Magnetic resonance imaging-guided adoptive cellular immunotherapy of central nervous system tumors with a T1 contrast agent.Mechanisms of malignant glioma immune resistance and sources of immunosuppressionGene therapy and targeted toxins for glioma.Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro modelsPlasmacytoid dendritic cells in the tumor microenvironment: immune targets for glioma therapeutics.Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas.Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications.Improved Adeno-associated Viral Gene Transfer to Murine Glioma.Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model.Mutations of the human interferon alpha-2b gene in brain tumor patients exposed to different environmental conditions.Dendritic cell therapy with interferon-alpha synergistically suppresses outgrowth of established tumors in a murine colorectal cancer model.The role of interferon-alpha in a successful murine tumor therapy.Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy.Intra-tumoral dendritic cells increase efficacy of peripheral vaccination by modulation of glioma microenvironmentA Kunjin replicon vector encoding granulocyte macrophage colony-stimulating factor for intra-tumoral gene therapy.Showing the Way: Oncolytic Adenoviruses as Chaperones of Immunostimulatory Adjuncts.Gene therapy and targeted toxins for glioma
P2860
Q27024830-3950A55E-7670-451B-9256-EEDEBA818F51Q28397886-785CAE7E-8209-45FB-B89D-BA2CF8B8B5FCQ31013320-A6F06A6B-7988-4F4F-B3A8-666A6FA7C78EQ33574853-9E745DBD-2B7B-4A7F-8DF5-6129AA5D17B6Q33744525-6D8F751D-1FA3-4497-805D-108C5D0EF313Q34076034-4CD3B0C3-8C65-42BD-AB6E-7A204359CD47Q34661793-55F014F0-C9A3-4A0C-9C68-A806F7518C30Q35118933-72AF0E6F-92E1-4194-B72D-1D24BD33FFD9Q35870475-9E14D216-D162-4A6A-91A6-4CA1271DE1D9Q36200438-E4154479-C95E-4255-9521-FDC917CBC4FEQ36367428-FD9A3BFF-169E-428A-8907-E2B0725DAAFFQ36377208-B20391AA-B88C-4C45-8364-5A7DF1D31F24Q37366610-0CC5795F-FD4A-453D-91E4-2E75774A22BEQ37814208-000BD5A9-A37E-45E9-85D3-8A031C2B3EFAQ38402828-C6BED0A7-A45E-4AD5-9D8F-DCC0BE99D570Q40383917-5A53F0CA-AF85-4BCF-BE65-D96FDCFE4F7FQ40403853-2F70F30C-2512-440B-9A6D-7A3ADC36B330Q42378527-826F7A07-D759-4BDA-B216-7187A22B39C9Q42426009-DA6067AA-90EE-49C8-9749-F8FA8CEF44AAQ42983982-90596CC9-8243-485D-93A5-2FDA5DB14CCCQ53883435-69E22A8D-DF35-4D9E-9838-6BDA864F9CA6Q57006162-0A1C562A-4D49-4A52-9CE2-B24609C6C44C
P2860
Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Sequential delivery of interfe ...... effective antitumor response.
@en
type
label
Sequential delivery of interfe ...... effective antitumor response.
@en
prefLabel
Sequential delivery of interfe ...... effective antitumor response.
@en
P2093
P2860
P356
P1433
P1476
Sequential delivery of interfe ...... effective antitumor response.
@en
P2093
Fellows-Mayle WK
Gambotto A
Kuwashima N
Papworth GD
Pollack IF
P2860
P2888
P304
P356
10.1038/SJ.GT.3302300
P577
2004-11-01T00:00:00Z
P6179
1013044786